Literature DB >> 21414089

Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats.

Makoto Bannai1, Nobuhiro Kawai, Kenji Nagao, Sayako Nakano, Daisuke Matsuzawa, Eiji Shimizu.   

Abstract

AIM: Glycine, one of the non-essential amino acids, has been reported to be effective in reducing negative symptoms of schizophrenia. Recently, we found that glycine improves subjective sleep quality in humans. The aim of this study was to investigate the effects of oral glycine administration on endogenous 5-hydroxytryptamine (5-HT) and dopamine in the prefrontal cortex (PFC) of living rats.
METHODS: Microdialysis probes were inserted stereotaxically into the rat prefrontal cortex. Cortical levels of 5-HT and dopamine were measured following oral administration of 1 or 2 g/kg glycine, 2 g/kg d-serine, or 2 g/kg L-serine.
RESULTS: Both glycine and d-serine significantly increased extracellular 5-HT levels for 10 min, whereas dopamine levels remained unchanged. L-serine, in contrast, had no significant effects on 5-HT levels.
CONCLUSIONS: It is possible that the increase in 5-HT in response to glycine and d-serine was mediated by N-methyl-D-aspartate receptors. The transient increase in 5-HT in the PFC might be associated with the alleviation of negative symptoms in patients with schizophrenia and the amelioration of sleep quality in patients with insomnia.
© 2011 The Authors. Psychiatry and Clinical Neurosciences © 2011 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414089     DOI: 10.1111/j.1440-1819.2010.02181.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  3 in total

1.  Orexin neurons receive glycinergic innervations.

Authors:  Mari Hondo; Naoki Furutani; Miwako Yamasaki; Masahiko Watanabe; Takeshi Sakurai
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

2.  A Comparative Randomized Controlled Clinical Trial on the Effectiveness, Safety, and Tolerability of a Homeopathic Medicinal Product in Children with Sleep Disorders and Restlessness.

Authors:  Miek C Jong; Lydia Ilyenko; Irina Kholodova; Cynthia Verwer; Julia Burkart; Stephan Weber; Thomas Keller; Petra Klement
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-08       Impact factor: 2.629

3.  Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.

Authors:  Kevin C F Fone; David J G Watson; Rodolphe I Billiras; Dorothee I Sicard; Anne Dekeyne; Jean-Michel Rivet; Alain Gobert; Mark J Millan
Journal:  Mol Neurobiol       Date:  2020-01-20       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.